Steroids inhalation

Maintenance treatment for asthma for those previously treated with oral steroids Inhalation Powder (Flovent Diskus) 500-1000 meg twice a day. Inhalation (Oral [Flovent]) 880 meg twice a day. 

Ifthepatient is using a bronchodilator inhaler concomitantly with a steroid inhaler, use the bronchodilator several minutes before using the corticosteroid to help the steroid penetrate into the bronchial tree... 

Mrs Patel is a frail (BMI 18) lady of 72 with well-controlled asthma using high-dose steroid inhalers and occasional oral courses during an exacerbation. She came in to show you her wrist, which is in a plaster cast. She wants your opinion as the orthopaedic consultant has said she has got osteoporosis and wants to send her for a special X-ray and start treatment. 

Q12 Would it be useful to prescribe Bill a bronchodilator or a steroid inhaler ... 

Q14 After his recovery from this acute bronchitis, would this patient benefit from a trial of a bronchodilator or steroid inhaler ... 

Bronchodilators, steroid inhalers, other asthma medication... 

Erythematous (acute atrophic) Patients with HIV, patients on broad-spectrum antibiotics or steroid inhalers Sensitive and painful erythematous mucosa with few, if any, white plaques lesions are generally on dorsal surface of tongue or hard palate, occasionally on soft palate, but any part of mucosa can be involved appear as flat red patches on the palate or atrophic patches on tongue dorsum with loss of papillae. 

Sjoblom E, Hojer J, Kulling PE, et al. 1999. A placebo-controlled experimental study of steroid inhalation therpy in ammonia-induced lung injury. J Toxicol Clin Toxicol 37(l) 59-67. 

The patient should rinse his or her mouth with water and expectorate (spit) following inhalation of steroids because steroid inhalants promote oral fungal infections. 

If I am in the red zone, it means I should take my cromolyn and steroid inhaler. ... 

The red zone indicates a medical alert—a bronchodilator should be taken and the child should seek medical attention for acute severe asthma. The cromolyn and steroid inhaler are not used for an acute asthma attack. 

The steroid inhaler does not cause the systemic problem of suppression of the adrenal gland and exposure of cells of the body to excess cortisol. The inhaler delivers the anti-inflammatory medication directly to the lungs, where effects are desired. 

Treatment may also be given by steroid inhaler (typically beclomethasone dipropionate) with the initial dose about five times the normal for the... 

Asthma is a chronic inflammatory disease. Therefore steroids represent the most important and most frequently used medication. Already after the fust treatment, steroids reduce cellular infiltration, inflammation, and the LAR, whereas changes in the EAR require prolonged treatment to lower the existent IgE levels. The mechanisms of steroid actions are complex and only incompletely understood. Besides their general antiinflammatory properties (see chapter glucocorticoids), the reduction of IL-4 and IL-5 production from T-lymphocytes is particularly important for asthma therapy. The introduction of inhaled steroids, which have dramatically limited side effects of steroids, is considered one of the most important advancements in asthma therapy. Inhaled steroids (beclomethasone, budesonide, fluticasone, triamcinolone, momethasone) are used in mild, moderate, and partially also in severe asthma oral steroids are used only in severe asthma and the treatment of status asthmaticus. Minor side effects of most inhaled steroids are hoarseness and candidasis, which are avoided by the prodrug steroid ciclesonide. 

Inhaled steroids (commonly used are beclomethasone, budesonide, triamcinolone, fluticasone, flunisolide) appear to attenuate the inflammatory response, to reduce bronchial hyperreactivity, to decrease exacerbations and to improve health status they may also reduce the risk of myocar dial infar ction, but they do not modify the longterm decline in lung function. Whether- steroids affect mortality remains unclear. Many patients appear to be resistant to steroids and large, long-term trials have shown only limited effectiveness of inhaled corticosteroid ther apy. Certainly, the benefit from steroids is smaller in COPD than in asthma. Topical side-effects of inhaled steroids are oropharyngeal candidiasis and hoarse voice. At the normal doses systemic side-effects of inhaled steroids have not been firmly established. The current recommendation is that the addition of inhaled gluco-coiticosteroids to bronchodilator treatment is appropriate for patients with severe to veiy sever e COPD. 

Qj Double the dose of your inhaled steroid for (7-10) days. 

In cases of severe acute asthmatic attacks, bronchodilators and steroids for direct dehveiy to the lungs may be needed in large doses. This is achieved by direct inhalation via a nebulizer device this converts a liquid into a mist or fine spray. The dmg is diluted in small volumes of Water for Injections BP before loading into the reservoir of the machine. This vehicle must be sterile and preservative-fiee and is therefore prepared as a terminally sterilized unit dose in polyethylene nebules. 

Figure 5 shows examples of two dry powder inhalers, the Turbuhaler and the Diskus, currently marketed in the United States for the delivery of the steroids, budesonide and fluticosone, respectively. Table 6 shows the major elements of a number of passive dry powder inhalers. In addition to the commercially available passive inhalation products, a number of active dispersion systems are under development the key characteristics of selected devices are shown in Table 7. 

A 22-year-oId male with a five-year history of bronchial asthma has developed increased frequency and severity of acute asthmatic attacks. A low dose of which inhaled steroid could be added to his treatment regimen ... 

The answer is c. (Hardman, p 666.) Inhalation therapy minimizes systemic effects of steroids. Of the agents above, beclomethasone is the only one delivered by mete red-dose inhaler (MDl). 

Inhaled corticosteroids are the preferred long-term control therapy for persistent asthma in all patients because of their potency and consistent effectiveness they are also the only therapy shown to reduce the risk of death from asthma. Comparative doses are included in Table 80-3. Most patients with moderate disease can be controlled with twice-daily dosing some products have once-daily dosing indications. Patients with more severe disease require multiple daily dosing. Because the inflammatory response of asthma inhibits steroid receptor binding, patients should be started on higher and more frequent doses and then tapered down once control has been achieved. The response to inhaled corticosteroids is delayed symptoms improve in most patients within the first 1 to 2 weeks and reach maximum improvement in 4 to 8 weeks. Maximum improvement in FEVj and PEF rates may require 3 to 6 weeks. 

Systemic corticosteroids (Table 80-4) are indicated in all patients with acute severe asthma not responding completely to initial inhaled /J2-agonist administration (every 20 minutes for three to four doses). Prednisone, 1 to 2 mg/kg/day (up to 40 to 60 mg/day), is administered orally in two divided doses for 3 to 10 days. Because short-term (1 to 2 weeks), high-dose systemic steroids do not produce serious toxicities, the ideal method is to use a short burst and then maintain the patient on appropriate long-term control therapy with inhaled corticosteroids. 

---